Viszeralchirurgie 2000; 35(1): 44-47
DOI: 10.1055/s-2000-11233
ORIGINALARBEIT
© Georg Thieme Verlag Stuttgart · New York

Malabsorption und Malnutrition bei entzündlichen Darmerkrankungen

E. F. Stange, J. Scheibner, G. Ball, K. Lange
  • Medizinische Klinik 1, Bereich Gastroenterologie/Hepatologie, Universitätsklinikum Lübeck
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Zusammenfassung

Malnutrition ist ein häufiges Problem bei entzündlichen Darmerkrankungen und auf verminderte Nahrungsaufnahme, Malabsorption, intestinale Verluste und eine gesteigerte Utilisation zurückzuführen. Eigentliche Resorptionsstörungen sind auf eine verminderte Resorptionsfläche, das Gallensäureverlustsyndrom oder auf eine bakterielle Fehlbesiedlung zurückzuführen. Die wichtigsten Probleme sind Gewichtsverlust, Hypoproteinämie und Anämie sowie die spezifischen Defizite von Eisen, Vitamin B12, Kalzium und Vitamin D sowie Zink.

Malabsorption and malnutrition in inflammatory bowel diseases.

Malnutrition is a common problem in inflammatory bowel diseases and is due to diminished enteral nutrition, malabsorption, intestinal losses as well as enhanced utilisation. Specific malabsorption may be secondary to a reduced resorptive surface area, bile acid losses and bacterial overgrowth. Major problems are weight loss, hypoproteinemia and anemia associated with deficiencies of iron, vitamin B12, calcium and vitamin D as well as zinc.

Literatur

  • 1 Rath H C, Caesar I, Roth M, Schölmerich J. Mangelzustände und Komplikationen bei chronisch entzündlichen Darmerkrankungen.  Med Klinik. 1998;  1 6-10
  • 2 Weterman I T, Biemond I, Peña A S. Mortality and causes of death in Crohn's disease. Review of 50 years' experience in Leiden University Hostpital.  Gut. 1990;  31 1387-1390
  • 3 Rigaud D, Angel L A, Cerf M, Carduner M J, Melchior J C, Sautier C, Rene E, Apfelbaum M, Mignon M. Mechanisms of decreased food intake during weight loss in adult Crohn's disease patients without obvious malabsorption.  Am J Clin Nutr. 1994;  60 775-781
  • 4 Andersson H, Dotevall G, Gillberg R, Jagenburg R, Kock N G. Absorption studies in patients with Crohn's disease and in patients with ulcerative colitis.  Acta med scand. 1971;  190 407-410
  • 5 Park R HR, Duncan A, Russell R I. Hypolactasia and Crohn's disease: a myth.  Am J Gastroenterol. 1990;  85 708-710
  • 6 Mishkin B, Yalovsky M, Mishkin S. Increased prevalence of lactose malabsorption in Crohn's disease patients at low risk for lactose malabsorption based on ethnic origin.  Am J Gastroenterol. 1997;  92 1148-1153
  • 7 Peña A S, Truelove S C. Hypolactasia and ulcerative colitis.  Gastroenterology. 1973;  64 400-404
  • 8 Dyer N H, Dawson A M. Malnutrition and malabsorption in Crohn's disease with reference to the effect of surgery.  Brit J Surg. 1973;  60 134-140
  • 9 Balzer K, Schmitt G, Reiners C, Goebell H. Befunde mit dem 75Selen-Homotaurocholsäure-Retentionstest (SeHCAT-Test) in der Diagnostik von Diarrhöen.  Med Klinik. 1995;  1 27-32
  • 10 Nyhlin H, Merrick M V, Eastwood M A. Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT.  Gut. 1994;  35 90-93
  • 11 Picarelli A, Greco M, Di Giovambattista F, Ramazzotti A, Cedrone C, Corazziari E, Torsoli A. Quantitative deterrnination of faecal fat, nitrogen and water by means of a spectrophotometric technique: near infrared reflectance analysis (NIRA). Assessment of its accuracy and reproducibility compared with chemical methods.  Clin Chim Acta. 1995;  31 147-156
  • 12 Schölmerich J, Hoppe-Seyler P, Gerok W. Extraintestinale Manifestationen bei entzündlichen Darmerkrankungen.  Therapiewoche. 1986;  36 520-532
  • 13 Jeppesen P B, Mortensen P B. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection.  Gut. 1998;  43 478-483
  • 14 Meryn S, Lochs H, Bettelheim P, Sertl K, Mulak K. Serumproteinkonzentrationen - Parameter für die Krankheitsaktivität bei Morbus Crohn?.  Leber Magen Darm. 1985;  15 160-164
  • 15 Beeken W L, Busch H J, Sylwester D L. Intestinal protein in Crohn's disease.  Gastroenterology. 1972;  62 207-215
  • 16 Meyers S, Wolke A, Field S P, Feuer E J, Johnson J W, Janowitz H D. Fecal α1-antitrypsin measurement: an indicator of Crohn's disease activity.  Gastroenterology. 1985;  89 13-18
  • 17 Schreiber S, Wedel S. Diagnosis and Treatment of anemia in inflammatory bowel disease.  Inflammatory Bowel Diseases. 1997;  3 204-216
  • 18 Gerson C D, Cohen N, Janowitz H D. Small intestinal absorptive function in regional enteritis.  Gastroenterology. 1973;  64 907-912
  • 19 Filipsson S, Hultén L, Lindstedt G. Malabsorption of fat and vitamin B12 before and after intestinal resection for Crohn's disease.  Scand J Gastroent. 1978;  13 529-536
  • 20 Vogelsang H, Ferenci P, Schilling R, Woloszczuk W, Haschke F, Lochs H, Meryn S, Gang A. Vitamin D Status in outpatients with Crohn's disease.  Eur J Gastroenterol Hepatol. 1994;  6 513-517
  • 21 Ghosh S, Cowen S, Hannan W J, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis.  Gastroenterology. 1994;  107 1031 -1039
  • 22 Jahnsen J, Falch J A, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study.  Gut. 1997;  40 313-319
  • 23 Schulte C, Dignass A U, Mann K, Goebell H. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease.  Inflammatory Bowel Disease. 1998;  4 268-275
  • 24 Krawitt E L, Beeken W L, Janney C D. Calcium absorption in Crohn's disease.  Gastroenterology. 1976;  71 251-254
  • 25 Bischoff S C, Herrmann A, Göke M, Manns M P, von zur Mühlen A, Brabant G. Altered bone metabolism in inflammatory bowel disease.  Am J Gastroenterol. 1997;  92 1157-1163
  • 26 Driscoll R H, Meredith S C, Sitrin M, Rosenberg I H. Vitamin D deficiency and bone disease in patients with Crohn's disease.  Gastroenterology. 1982;  83 1252-1258
  • 27 Silvennoinen J. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease.  J Intern Med. 1996;  239 131-137
  • 28 Robinson R J, Al Azzawi F, Iqbal S J, Kryswcki T, Almond L, Abrams K, Mayberry J F. Osteoporosis and determinants of bone density in patients with Crohn's disease.  Dig Dis Sci. 1998;  43 2500-2506
  • 29 Schoelmerich J, Becher M S, Hoppe-Seyler P, Matern S, Haeussinger D, Loehle E, Keottgen E, Gerok W. Zinc and vitamin A deficiency in patients with Crohn's disease is correlated with activity but not with localization or extent of the disease.  Hepato Gastroenterol. 1985;  32 34-38
  • 30 Howard L, Ovesen L, Satya-Murti S, Chu R. Reversible neurological symptoms caused by vitamin E deficiency in a patient with short bowel syndrome.  Am J Clin Nutr. 1982;  36 1243-1249
  • 31 Stange E F, Schreiber S, Raedler A, Stallmach A, Schölmerich J, Loeschke K, Starlinger M, Fischbach W, Caspary WF. Therapie des Morbus Crohn - Ergebnisse einer Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten.  Z Gastroenterol. 1997;  35 541-554
  • 32 Rannem T, Ladefoged K, Hylander E, Hegnhoj J, Staun M. Selenium depletion in patients with gastrointestinal diseases: are there any predictive factors?.  Scand J Gastroenterol. 1998;  33 1057-1061
  • 33 Ringstad J, Kildebo S, Thomassen Y. Serum selenium, copper and zinc concentrations in Crohn's disease and ulcerative Colitis.  Scand J Gastroenterol. 1993;  28 605-608

Prof. Dr. Eduard F. Stange

Medizinische Klinik IBereich Gastroenterologie/HepatologieUniversitätsklinikum Lübeck

Ratzeburger Allee 16023538 Lübeck